Doctors to FDA: Don’t Call Them ‘Breakthrough’ Drugs

Livescience - Cites a study conducted by researchers at the Geisel School of Medicine and Carnegie Mellon University, which found that the U.S. Food and Drug Administration should avoid using words like "breakthrough" and "promising" to describe new drugs when making announcements aimed at the public because it does not necessarily mean that a drug is effective or that it will help patients live longer. (Picked up by Yahoo News UK, Yahoo News Singapore, and Yahoo News Canada.)